Novel exosome-based drug delivery system for synergistic cancer treatment

FHS
August 12, 2024
11:58 pm

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer metastases, leading to a low survival rate for ovarian cancer patients.

Indiana Advances Psilocybin Research with New Funding Initiative | Psychedelic Invest

Governor Eric Holcomb of Indiana has recently enacted a law that earmarks funds for clinical trials to explore the therapeutic effects of psilocybin. This development

April 12, 2024

Steroid Fails to Boost Survival in Advanced HIV Patients With TB Meningitis

Adding dexamethasone to treatment for tuberculous (TB) meningitis among heavily immunosuppressed HIV-positive patients in a low-resource setting did not significantly improve survival or confer any

October 12, 2023

Teleflex catheter kit recall linked to 31 injuries, 3 deaths

Dive Brief: Teleflex has recalled catheter kits linked to reports of 31 injuries and three deaths, the Food and Drug Administration said Thursday. The company

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.